Patient Power’s Andrew Schorr survived leukemia in-part because of the treatment he received while participating in a phase II clinical trial. He received a now-FDA-approved combination treatment ten years before it was approved. Clinical trials may not be the right answer for you, but they are an important consideration, especially when facing an incurable or life-altering condition. You may have the opportunity to receive “tomorrow’s medicine today” and by participating you can help advance knowledge about your condition, all while receiving close monitoring and the best care available.
A Cancer Patient’s Insider View of the FDA
Musa Mayer of New York City was diagnosed with breast cancer 22 years ago. Since then, she has become a patient advocate and author of the highest integrity. She also...
Understanding Clinical Studies for PKU
Do you have questions about what a clinical study is? What do you need to consider when deciding whether to participate in a clinical study? Our first webcast in the...
New Hope for Melanoma
After many years with no new treatments for Melanoma, the FDA has just approved a breakthrough treatment for the disease. In this program two leading experts from the Seattle Cancer...